Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 17, Number 1—January 2011
Dispatch

Possible Interruption of Measles Virus Transmission, Uganda, 2006–2009

Frederick N. BaliraineComments to Author , Josephine Bwogi, Henry Bukenya, Ronald Seguya, Theopista Kabaliisa, Annet Kisakye, William B. Mbabazi, and Sheilagh B. Smit
Author affiliations: Author affiliations: University of California, San Francisco, California, USA (F.N. Baliraine); Uganda Virus Research Institute, Entebbe, Uganda (J. Bwogi, H. Bukenya, R. Seguya, T. Kabaliisa); Uganda National Expanded Program for Immunization, Entebbe (A. Kisakye); World Health Organization, Kampala, Uganda (A. Kisakye); Management Sciences for Health/Strengthening Pharmaceutical Systems, Juba, Sudan (W.B. Mbabazi); National Institute for Communicable Diseases, Johannesburg, South Africa (S.B. Smit)

Main Article

Figure 1

Laboratory-confirmed measles cases in Uganda, 2006‒2009. Data from the accelerated measles control period 2003‒2005 are included for comparison. The surge in measles cases during 2006 was caused by a resumption of measles outbreaks after a 3-year lag period, due to an accumulated number of susceptible persons (1).

Figure 1. Laboratory-confirmed measles cases in Uganda, 2006‒2009. Data from the accelerated measles control period 2003‒2005 are included for comparison. The surge in measles cases during 2006 was caused by a resumption of measles outbreaks after a 3-year lag period, due to an accumulated number of susceptible persons (1).

Main Article

References
  1. Mbabazi  WB, Nanyunja  M, Makumbi  I, Braka  F, Baliraine  FN, Kisakye  A, Achieving measles control: lessons from the 2002–06 measles control strategy for Uganda. Health Policy Plan. 2009;24:261–9. DOIPubMedGoogle Scholar
  2. Rota  PA, Featherstone  DA, Bellini  WJ. Molecular epidemiology of measles virus. In: Griffin DE, Oldstone MBA, editors. Measles: pathogenesis and control. Berlin: Springer-Verlag; 2009. p. 129–50.
  3. Muwonge  A, Nanyunja  M, Rota  PA, Bwogi  J, Lowe  L, Liffick  SL, New measles genotype, Uganda. Emerg Infect Dis. 2005;11:1522–6.PubMedGoogle Scholar
  4. World Health Organization. Manual for the laboratory diagnosis of measles and rubella virus infection. 2nd ed. Geneva (Switzerland); The Organization; 2007.
  5. Smit  SB, Hardie  D, Tiemessen  CT. Measles virus genotype B2 is not inactive: evidence of continued circulation in Africa. J Med Virol. 2005;77:550–7. DOIPubMedGoogle Scholar
  6. Kouomou  DW, Nerrienet  E, Mfoupouendoun  J, Tene  G, Whittle  H, Wild  TF. Measles virus strains circulating in central and west Africa: geographical distribution of two B3 genotypes. J Med Virol. 2002;68:433–40. DOIPubMedGoogle Scholar
  7. El Mubarak  HS, van de Bildt  MW, Mustafa  OA, Vos  HW, Mukhtar  MM, Ibrahim  SA, Genetic characterization of wild-type measles viruses circulating in suburban Khartoum, 1997–2000. J Gen Virol. 2002;83:1437–43.PubMedGoogle Scholar
  8. Rota  J, Lowe  L, Rota  P, Bellini  W, Redd  S, Dayan  G, Identical genotype B3 sequences from measles patients in 4 countries, 2005. Emerg Infect Dis. 2006;12:1779–81.PubMedGoogle Scholar
  9. Central Intelligence Agency. The world fact book: Uganda [cited 2010 Aug 18]. https://www.cia.gov/library/publications/the-world-factbook/geos/ug.html
  10. Ferrari  MJ, Grais  RF, Bharti  N, Conlan  AJ, Bjornstad  ON, Wolfson  LJ, The dynamics of measles in sub-Saharan Africa. Nature. 2008;451:679–84. DOIPubMedGoogle Scholar
  11. World Health Organization. Implementing intregrated disease surveillance and response. Wkly Epidemiol Rec. 2003;78:233–40.
  12. World Health Organization. The RED strategy [cited 2010 May 13]. http://www.who.int/immunization_delivery/systems_policy/red/en
  13. World Health Organization. New genotype of measles virus and update on global distribution of measles genotypes. Wkly Epidemiol Rec. 2005;80:348–51.
  14. Biellik  R, Madema  S, Taole  A, Kutsulukuta  A, Allies  E, Eggers  R, First 5 years of measles elimination in southern Africa: 1996–2000. Lancet. 2002;359:1564–8. DOIPubMedGoogle Scholar
  15. Otten  MW Jr, Okwo-Bele  JM, Kezaala  R, Biellik  R, Eggers  R, Nshimirimana  D. Impact of alternative approaches to accelerated measles control: experience in the African region, 1996–2002. J Infect Dis. 2003;187:S36–43. DOIPubMedGoogle Scholar

Main Article

Page created: July 18, 2011
Page updated: July 18, 2011
Page reviewed: July 18, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external